https://scholars.lib.ntu.edu.tw/handle/123456789/635137
標題: | Who needs to be screened for primary aldosteronism? | 作者: | Huang, Wei-Chieh Liu, Feng-Hsuan Cheng, Hao-Min Tsai, Yi-Chun Huang, Yen-Ta TAI-SHUAN LAI YEN-HUNG LIN VIN-CENT WU HSIEN-LI KAO Jia-Yin Hou, Charles KWAN-DUN WU Chen, Szu-Tah Er, Leay Kiaw |
關鍵字: | Aldosterone renin ratio; Hypertension; Primary aldosteronism; Screen | 公開日期: | 24-八月-2023 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | The prevalence of patients with primary aldosteronism (PA) is about 5%-15% in hypertensive patients, and it is common cause of secondary hypertension in clinical practice. Two major causes of PA are noted, namely bilateral adrenal hyperplasia and aldosterone-producing adenoma, and the general diagnosis is based on three steps: (1) screening, (2) confirmatory testing, and (3) subtype differentiation (Figure 1). The recommendation for screening patients is at an increased risk of PA, here we focus on which patients should be screened for PA, not only according to well-established guidelines but for potential patients with PA. We recommend screening for 1) patients with resistant or persistent hypertension, 2) hypertensive patients with hypokalemia (spontaneous or drug-induced), 3) young hypertensive patients (age <40 years), and 4) all hypertensive patients with a history of PA in first-degree relatives. Moreover, we suggest screening for 1) hypertensive patients themselves or first-degree relatives with early target organ damage, such as stroke and other diseases, 2) all hypertensive patients with a concurrent adrenal incidentaloma, 3) hypertensive patients with obstructive sleep apnea, 4) hypertensive patients with atrial fibrillation unexplained by structural heart defects and/or other conditions resulting in the arrhythmia, 5) hypertensive patients with anxiety and other psychosomatic symptoms, and 6) hypertensive patients without other comorbidities to maintain cost-effectiveness. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/635137 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2023.08.021 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。